T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 5, 2010, Pages 541-545

  Welschinger, Robert ^a   Kew, Michael C ^a,b,c   Viana, Raquel ^a   Badri, Motasim ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Core promoter mutations; Genotypes and subgenotypes; Hepatitis B virus; Hepatocellular carcinoma; Southern African Blacks; T1653

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ENHANCER REGION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEGRO; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS CARRIER; VIRUS CORE; VIRUS GENOME;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARCINOMA, HEPATOCELLULAR; ENHANCER ELEMENTS, GENETIC; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; SOUTH AFRICA; YOUNG ADULT;

EID: 77951287821     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283344991     Document Type: Article

References (22)

1. Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 isolates. Arch Virol 1998; 143:2313-2316.
2. Takahashi K, Ohta Y, Kanai K, Akahane Y, Iwasa Y, Hino K, et al. Clinical implications of mutations C-to-T 1653 and T-to-C/A/G1753 of hepatitis B virus genome in chronic liver disease. Arch Virol 1999; 144:1299-1308.
3. Tanaka Y, Mukaide M, Orito E, Yuen YF, Ho K, Kurbanov T, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006; 45:646-653.
4. Ito K, Tanaka Y, Orita E, Sugiyama M, Fujiwara K, Sugauchi F, et al. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis. 2006; 42:1-7.
5. Ito K, Tanaka Y, Kato M, Fujiwara K, Sugauchi F, Salamoto T, et al. Comparison of complete sequences of hepatitis B virus genotype C between carriers and hepatocellular carcinoma patients before and after seroconversion. J Gastroenterol 2007; 42:837-844.
6. Shinkai N, Tanaka Y, Ito K, Mukaide M, Hasegawa I, Asahina Y, et al. Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients with genotype C2. J Clin Microbiol 2007; 45:3191-3197.
7. Yuen MF, Tanaka Y, Shinhai N, Poon RT, But Dy, Fong DY, et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008; 57:98-102.
8. Kramvis A, Kew MC. Epidemiology of hepatitis B virus and its genotypes in Africa, and the clinical associations of the genotypes. Hepatol Res 2007; 37:S9-S19.
9. Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantuspeaking sub-Saharan Africans. J Med Virol 2005; 75:513-521.
10. Kew MC, de Groote M, Roggendorff J, Desmyter J, Frosner G, Deinhardt F. Hepatocellular cancer in southern African Blacks: HBeAg, anti HBe, IgManti HBc and other markers of hepatitis-B. In: Maupas P, Melnick JL, editors. Progr med virol Karger Basel: 1981. Basle: Karger. pp. 41-48.
11. Dusheiko GM, Bowyer S, Sjogren MH, Ritchie MJ, Santos AP, Kew MC. Replication of hepatitis-B virus in adult carriers in an endemic area. J Infect Dis 1985; 152:566-570.
12. Owiredu WKBA, Kramvis A, Kew MC. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: Possible association with recombination between genotypes A and D. J Med Virol 2001; 64:441-454.
13. Kramvis A, Kew MC, Bukofzer S. Hepatitis B virus mutants in serum and liver tissue of southern African Blacks with hepatocellular carcinoma. J Hepatol 1998; 28:132-141.
14. Kwok S, Higuchi R. Avoiding false-positives with PCR. Nature 1989; 339:237-238.
15. Higgins DG, Thompson JD, Gibson TJ. Using CLUSTAL for multiple sequence alignments. Methods Enzymol 1996; 266:383-402.
16. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, MacWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23:2947-2948.
17. Hasegawa I, Tanaka Y, Kramvis A, Kato T, Sugauchi F, Acharya SK, et al. Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies. J Virol 2004; 78:7575-7581.
18. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997; 175:1285-1293.
19. Yuh CH, Chang YL, Ting LP. Transcriptional regulation of the precore and pregenomic RNAs of hepatitis B virus. J Virol 1992; 66:4073-4084.
20. Ogata N, Miller RH, Ishak K, Purcell RH. The complete nucleotide sequence of a core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993; 194:263-276.
21. Kaneko M, Uchida T, Moriyama Y, Arakawa Y, Shikata T, Gotoh H, et al. Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis. J Med Virol 1995; 47:204-208.
22. Uchida T, Saitoh T, Shinzawa H. Mutations of the X region of hepatitis B virus and their clinical implications. Pathol Int 1997; 47:183-193.